FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:SLC25A25-TCEB3

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: SLC25A25-TCEB3
FusionPDB ID: 82621
FusionGDB2.0 ID: 82621
HgeneTgene
Gene symbol

SLC25A25

TCEB3

Gene ID

114789

6924

Gene namesolute carrier family 25 member 25elongin A
SynonymsMCSC|PCSCL|SCAMC-2SIII|SIII p110|TCEB3|TCEB3A
Cytomap

9q34.11

1p36.11

Type of geneprotein-codingprotein-coding
Descriptioncalcium-binding mitochondrial carrier protein SCaMC-2mitochondrial ATP-Mg/Pi carrier protein 3mitochondrial Ca(2+)-dependent solute carrier protein 3short calcium-binding mitochondrial carrier 2small calcium-binding mitochondrial carrier 2solute carrelongin-ARNA polymerase II transcription factor SIII subunit A1elongin 110 kDa subunittranscription elongation factor B (SIII), polypeptide 3 (110kDa, elongin A)transcription elongation factor B alpha subunittranscription elongation factor B polypept
Modification date2020031320200313
UniProtAcc..
Ensembl transtripts involved in fusion geneENST idsENST00000373068, ENST00000373069, 
ENST00000373064, ENST00000373066, 
ENST00000432073, ENST00000433501, 
ENST00000487554, ENST00000418390, 
ENST00000609199, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score8 X 5 X 6=2406 X 5 X 3=90
# samples 86
** MAII scorelog2(8/240*10)=-1.58496250072116
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(6/90*10)=-0.584962500721156
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: SLC25A25 [Title/Abstract] AND TCEB3 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: SLC25A25 [Title/Abstract] AND TCEB3 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)SLC25A25(130830859)-TCEB3(24075511), # samples:1
Anticipated loss of major functional domain due to fusion event.SLC25A25-TCEB3 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
SLC25A25-TCEB3 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
SLC25A25-TCEB3 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
SLC25A25-TCEB3 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr9:130830859/chr1:24075511)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across SLC25A25 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across TCEB3 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000373068SLC25A25chr9130830859-ENST00000418390TCEB3chr124075511+5110380292623864
ENST00000373068SLC25A25chr9130830859-ENST00000609199TCEB3chr124075511+2944380292623864
ENST00000373069SLC25A25chr9130830859-ENST00000418390TCEB3chr124075511+5018288272531834
ENST00000373069SLC25A25chr9130830859-ENST00000609199TCEB3chr124075511+2852288272531834

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000373068ENST00000418390SLC25A25chr9130830859-TCEB3chr124075511+0.0015095150.99849045
ENST00000373068ENST00000609199SLC25A25chr9130830859-TCEB3chr124075511+0.004844610.99515545
ENST00000373069ENST00000418390SLC25A25chr9130830859-TCEB3chr124075511+0.0014397410.99856025
ENST00000373069ENST00000609199SLC25A25chr9130830859-TCEB3chr124075511+0.0045794520.9954205

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for SLC25A25-TCEB3

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
SLC25A25chr9130830859TCEB3chr12407551128885GLRRLGLHRTEGELQLLKYLKKLSTL
SLC25A25chr9130830859TCEB3chr124075511380115GLRRLGLHRTEGELQLLKYLKKLSTL

Top

Potential FusionNeoAntigen Information of SLC25A25-TCEB3 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
SLC25A25-TCEB3_130830859_24075511.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B44:03GELQLLKY0.99980.86461119
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B18:01GELQLLKY0.99650.63991119
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B27:05HRTEGELQL0.99940.8207716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B27:02HRTEGELQL0.99940.5976716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B27:04HRTEGELQL0.99930.7355716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B27:07HRTEGELQL0.99930.7112716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B39:24HRTEGELQL0.99830.7046716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B39:06HRTEGELQL0.99780.8947716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B39:01HRTEGELQL0.99760.9257716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B44:03GELQLLKYL0.99680.8721120
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B14:01HRTEGELQL0.99620.9059716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B14:02HRTEGELQL0.99620.9059716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B13:01GELQLLKYL0.99520.64951120
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B38:02HRTEGELQL0.9910.9742716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B38:01HRTEGELQL0.99020.9748716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B15:10HRTEGELQL0.80180.8167716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B48:01HRTEGELQL0.78690.8123716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B15:37HRTEGELQL0.76310.8275716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B15:18HRTEGELQL0.59810.9112716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B39:13GELQLLKYL0.27280.72731120
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B07:10HRTEGELQL0.00950.5297716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B27:02HRTEGELQLL0.99980.5661717
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B27:04HRTEGELQLL0.99980.7056717
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B27:05HRTEGELQLL0.99980.811717
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B44:03TEGELQLLKY0.99940.9153919
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B27:07HRTEGELQLL0.99930.6624717
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B39:24HRTEGELQLL0.99720.6783717
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B39:01HRTEGELQLL0.9940.9238717
SLC25A25-TCEB3chr9130830859chr124075511380HLA-A03:12RTEGELQLLK0.99050.5068818
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B39:01LHRTEGELQL0.98160.972616
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B39:24LHRTEGELQL0.98110.8502616
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B38:02HRTEGELQLL0.97960.9735717
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B38:01HRTEGELQLL0.97390.9733717
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B18:01TEGELQLLKY0.97290.7934919
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B15:10LHRTEGELQL0.92140.8779616
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B38:01LHRTEGELQL0.91560.9918616
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B38:02LHRTEGELQL0.91020.9915616
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B15:37LHRTEGELQL0.87570.8953616
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B07:10LHRTEGELQL0.54490.6363616
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B27:05HRTEGELQLLK0.99960.721718
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B38:01LHRTEGELQLL0.98540.9901617
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B27:07GLHRTEGELQL0.98070.8736516
SLC25A25-TCEB3chr9130830859chr124075511380HLA-A02:22GLHRTEGELQL0.93710.5726516
SLC25A25-TCEB3chr9130830859chr124075511380HLA-A02:27GLHRTEGELQL0.82280.6142516
SLC25A25-TCEB3chr9130830859chr124075511380HLA-A02:60GLHRTEGELQL0.63540.5468516
SLC25A25-TCEB3chr9130830859chr124075511380HLA-A02:24GLHRTEGELQL0.63380.5143516
SLC25A25-TCEB3chr9130830859chr124075511380HLA-A02:67GLHRTEGELQL0.63380.5143516
SLC25A25-TCEB3chr9130830859chr124075511380HLA-A02:30GLHRTEGELQL0.63380.5143516
SLC25A25-TCEB3chr9130830859chr124075511380HLA-A02:20GLHRTEGELQL0.52180.5263516
SLC25A25-TCEB3chr9130830859chr124075511380HLA-A02:29GLHRTEGELQL0.50830.5128516
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C05:09RTEGELQLL10.9779817
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C08:15RTEGELQLL0.99990.9841817
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B27:14HRTEGELQL0.99940.7923716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C07:95HRTEGELQL0.99850.8502716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B39:09HRTEGELQL0.99820.8537716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B39:12HRTEGELQL0.99790.9285716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C07:05HRTEGELQL0.99780.979716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C07:27HRTEGELQL0.99770.9738716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C07:29HRTEGELQL0.99570.9597716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C15:06RTEGELQLL0.99510.9705817
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C07:13HRTEGELQL0.99360.9576716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B27:03HRTEGELQL0.97280.8433716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C07:46HRTEGELQL0.96790.9537716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B39:05HRTEGELQL0.95810.9196716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B73:01HRTEGELQL0.91840.8667716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C07:19HRTEGELQL0.87150.8817716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C07:10HRTEGELQL0.85760.9836716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C07:67HRTEGELQL0.83620.9711716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C07:80HRTEGELQL0.83620.9711716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B39:08GELQLLKYL0.56950.73161120
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B14:03HRTEGELQL0.47290.8913716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C12:16HRTEGELQL0.0580.968716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C07:95HRTEGELQLL0.99880.8586717
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B27:03HRTEGELQLL0.99610.8368717
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B39:12HRTEGELQLL0.99440.9271717
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B39:05HRTEGELQLL0.92550.9175717
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B39:05LHRTEGELQL0.91240.9702616
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B27:14HRTEGELQLLK0.99920.6509718
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B27:03HRTEGELQLLK0.98010.7472718
SLC25A25-TCEB3chr9130830859chr124075511380HLA-A02:01GLHRTEGELQL0.63380.5143516
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B44:13GELQLLKY0.99980.86461119
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B44:26GELQLLKY0.99980.86461119
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B44:07GELQLLKY0.99980.86461119
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B40:04TEGELQLL0.99950.7539917
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B18:08GELQLLKY0.99740.59741119
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B18:05GELQLLKY0.99650.63991119
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B18:06GELQLLKY0.9960.65091119
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B18:03GELQLLKY0.99490.62191119
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B18:11GELQLLKY0.9910.61221119
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B41:03TEGELQLL0.90280.6348917
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C05:01RTEGELQLL10.9779817
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C04:03RTEGELQLL10.9665817
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C08:02RTEGELQLL0.99990.9841817
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B27:08HRTEGELQL0.99940.7866716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B27:10HRTEGELQL0.99930.8294716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B27:06HRTEGELQL0.99920.7354716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B27:09HRTEGELQL0.99910.8072716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C07:01HRTEGELQL0.99860.8497716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B39:02HRTEGELQL0.99820.9714716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B39:31HRTEGELQL0.99720.925716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B44:13GELQLLKYL0.99680.8721120
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B44:26GELQLLKYL0.99680.8721120
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B44:07GELQLLKYL0.99680.8721120
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C15:05RTEGELQLL0.99420.9797817
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C15:02RTEGELQLL0.99150.9725817
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B38:05HRTEGELQL0.99020.9748716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C07:17HRTEGELQL0.98830.9736716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C18:01HRTEGELQL0.96840.9498716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C06:08HRTEGELQL0.95940.9843716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C07:04HRTEGELQL0.85560.9574716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C07:02HRTEGELQL0.83620.9711716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C06:06HRTEGELQL0.77160.9892716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B39:11HRTEGELQL0.75330.8055716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C07:22HRTEGELQL0.74590.8203716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B15:09HRTEGELQL0.71650.912716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C03:67HRTEGELQL0.68690.9902716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C04:04HRTEGELQL0.65670.9717716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B41:03GELQLLKYL0.59130.50641120
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B57:02RTEGELQLL0.47080.9739817
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B39:02GELQLLKYL0.20910.72791120
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C06:02HRTEGELQL0.07740.9912716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C06:17HRTEGELQL0.07740.9912716
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B27:08HRTEGELQLL0.99980.763717
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B27:09HRTEGELQLL0.99960.8196717
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B27:06HRTEGELQLL0.99950.714717
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B44:13TEGELQLLKY0.99940.9153919
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B44:07TEGELQLLKY0.99940.9153919
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B44:26TEGELQLLKY0.99940.9153919
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B39:31HRTEGELQLL0.99480.9235717
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C06:08HRTEGELQLL0.98950.9812717
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C07:22HRTEGELQLL0.98910.8213717
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B38:05HRTEGELQLL0.97390.9733717
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B18:05TEGELQLLKY0.97290.7934919
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B27:09LHRTEGELQL0.96450.9414616
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B38:05LHRTEGELQL0.91560.9918616
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C06:17HRTEGELQLL0.90240.99717
SLC25A25-TCEB3chr9130830859chr124075511380HLA-C06:02HRTEGELQLL0.90240.99717
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B18:11TEGELQLLKY0.90080.7474919
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B39:11LHRTEGELQL0.81490.909616
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B15:09LHRTEGELQL0.74730.9602616
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B27:10HRTEGELQLLK0.99950.7541718
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B27:08GLHRTEGELQL0.9920.7412516
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B27:06GLHRTEGELQL0.9890.8408516
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B38:05LHRTEGELQLL0.98540.9901617
SLC25A25-TCEB3chr9130830859chr124075511380HLA-B27:09GLHRTEGELQL0.96690.8224516

Top

Potential FusionNeoAntigen Information of SLC25A25-TCEB3 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)

Top

Fusion breakpoint peptide structures of SLC25A25-TCEB3

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
5071LHRTEGELQLLKYLSLC25A25TCEB3chr9130830859chr124075511380

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of SLC25A25-TCEB3

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN5071LHRTEGELQLLKYL-7.9962-8.1096
HLA-B14:023BVN5071LHRTEGELQLLKYL-5.70842-6.74372
HLA-B52:013W395071LHRTEGELQLLKYL-6.83737-6.95077
HLA-B52:013W395071LHRTEGELQLLKYL-4.4836-5.5189
HLA-A11:014UQ25071LHRTEGELQLLKYL-10.0067-10.1201
HLA-A11:014UQ25071LHRTEGELQLLKYL-9.03915-10.0745
HLA-A24:025HGA5071LHRTEGELQLLKYL-6.56204-6.67544
HLA-A24:025HGA5071LHRTEGELQLLKYL-5.42271-6.45801
HLA-B44:053DX85071LHRTEGELQLLKYL-7.85648-8.89178
HLA-B44:053DX85071LHRTEGELQLLKYL-5.3978-5.5112
HLA-A02:016TDR5071LHRTEGELQLLKYL-3.37154-4.40684

Top

Vaccine Design for the FusionNeoAntigens of SLC25A25-TCEB3

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
SLC25A25-TCEB3chr9130830859chr1240755111119GELQLLKYCTCCAGCTATTGAAATATTTGAAG
SLC25A25-TCEB3chr9130830859chr1240755111120GELQLLKYLCTCCAGCTATTGAAATATTTGAAGAAA
SLC25A25-TCEB3chr9130830859chr124075511516GLHRTEGELQLCACCGCACCGAGGGCGAGCTCCAGCTATTGAAA
SLC25A25-TCEB3chr9130830859chr124075511616LHRTEGELQLCGCACCGAGGGCGAGCTCCAGCTATTGAAA
SLC25A25-TCEB3chr9130830859chr124075511617LHRTEGELQLLCGCACCGAGGGCGAGCTCCAGCTATTGAAATAT
SLC25A25-TCEB3chr9130830859chr124075511716HRTEGELQLACCGAGGGCGAGCTCCAGCTATTGAAA
SLC25A25-TCEB3chr9130830859chr124075511717HRTEGELQLLACCGAGGGCGAGCTCCAGCTATTGAAATAT
SLC25A25-TCEB3chr9130830859chr124075511718HRTEGELQLLKACCGAGGGCGAGCTCCAGCTATTGAAATATTTG
SLC25A25-TCEB3chr9130830859chr124075511817RTEGELQLLGAGGGCGAGCTCCAGCTATTGAAATAT
SLC25A25-TCEB3chr9130830859chr124075511818RTEGELQLLKGAGGGCGAGCTCCAGCTATTGAAATATTTG
SLC25A25-TCEB3chr9130830859chr124075511917TEGELQLLGGCGAGCTCCAGCTATTGAAATAT
SLC25A25-TCEB3chr9130830859chr124075511919TEGELQLLKYGGCGAGCTCCAGCTATTGAAATATTTGAAG

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence

Top

Information of the samples that have these potential fusion neoantigens of SLC25A25-TCEB3

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
UCECSLC25A25-TCEB3chr9130830859ENST00000373068chr124075511ENST00000418390TCGA-PG-A7D5-01A

Top

Potential target of CAR-T therapy development for SLC25A25-TCEB3

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to SLC25A25-TCEB3

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to SLC25A25-TCEB3

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource